Martina Veigl

2.5k citations

38 papers · 1.9k indexed · 1 hit paper · h-index 20

Co-authors: W. David Sedwick Sanford D. Markowitz James Lutterbaugh Paul Modrich Guo‐Min Li Thomas Vanaman Lakshmi Kasturi James T. Drummond
Topics: Genetic factors in colorectal cancer (14 papers)DNA Repair Mechanisms (10 papers)Cancer Genomics and Diagnostics (5 papers)
Cited by: Pathology and Forensic Medicine Cancer Research Oncology
Journals: Proceedings of the National Academy of Sciences Nature Communications Blood
Partner nations: United States China Spain

In The Last Decade

Martina Veigl

38 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biallelic inactivation of hMLH 1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers

1998 507 citations Martina Veigl, Lakshmi Kasturi et al. profile →

Peers

Countries citing papers authored by Martina Veigl

Since Specialization

Citations

This map shows the geographic impact of Martina Veigl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Veigl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Veigl more than expected).

Fields of papers citing papers by Martina Veigl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Veigl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Veigl. The network helps show where Martina Veigl may publish in the future.

Co-authorship network of co-authors of Martina Veigl

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Veigl. A scholar is included among the top collaborators of Martina Veigl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Veigl. Martina Veigl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer 2022 ·Nature Communications ·Yujun Hao,Baoyu He,Liping Wu,(unknown),Chao Wang,Ting Wang,Longci Sun,Yanhua Zhang,Yangyang Zhan,Yiqing Zhao,Sanford D. Markowitz,Martina Veigl,Ronald A. Conlon,Zhenghe Wang	24
2	A nonrandomized trial of vitamin D supplementation for Barrett’s esophagus 2017 ·PLoS ONE ·Linda C. Cummings,Prashanthi N. Thota,Joseph Willis,Yanwen Chen,Gregory S. Cooper,Nancy Furey,(unknown),(unknown),John A. Dumot,Ashley L. Faulx,Stephen P. Fink,Adam Kresak,(unknown),Jill S. Barnholtz‐Sloan,Patrick Leahy,Martina Veigl,Amitabh Chak,Sanford D. Markowitz	9
3	A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease 2016 ·Frontiers in Medicine ·Haley Gittleman,Alona Merkulova,Omar Alhalabi,Evi X. Stavrou,Martina Veigl,Jill S. Barnholtz‐Sloan,Alvin H. Schmaier	16
4	Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility 2013 ·PLoS ONE ·Cheryl L. Thompson,Stephen P. Fink,James Lutterbaugh,Robert C. Elston,Martina Veigl,Sanford D. Markowitz,(unknown)	10
5	Global mutational profiling of formalin-fixed human colon cancers from a pathology archive 2012 ·Modern Pathology ·Mark D. Adams,Martina Veigl,Zhenghe Wang,(unknown),Shuying Sun,Kishore Guda,Xiaoqing Yu,Sanford D. Markowitz,Joseph Willis	17
6	DNA mismatch repair (MMR)‐dependent 5‐fluorouracil cytotoxicity and the potential for new therapeutic targets 2009 ·British Journal of Pharmacology ·Long Shan Li,Julio C. Morales,Martina Veigl,David Sedwick,Sheldon Greer,Mark Meyers,Mark W. Wagner,Richard Fishel,David A. Boothman	60
7	Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability 2000 ·Oncogene ·Ai‐Hong Ma,Liang Xia,Susan J. Littman,Sandra E. Swinler,(unknown),(unknown),(unknown),Lakshmi Kasturi,James Lutterbaugh,Paul Modrich,Martina Veigl,Sanford D. Markowitz,W. David Sedwick	23
8	Cytotoxicity and Mutagenicity of Frameshift-Inducing Agent ICR191 in Mismatch Repair-Deficient Colon Cancer Cells 2000 ·JNCI Journal of the National Cancer Institute ·(unknown),James R. Eshleman,(unknown),Ai‐Hong Ma,(unknown),Sanford D. Markowitz,W. David Sedwick,Martina Veigl	15
9	Mice over-expressing human O6alkylguanine-DNA alkyltransferase selectively reduce O6methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea 1999 ·Oncogene ·Esther R. Allay,Martina Veigl,Stanton L. Gerson	38
10	Mismatch repair and drug responses in cancer 1999 ·Drug Resistance Updates ·W. David Sedwick,Sanford D. Markowitz,Martina Veigl	6
11	Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53 1998 ·Oncogene ·James R. Eshleman,Graham Casey,(unknown),W. David Sedwick,Sandra E. Swinler,Martina Veigl,James K. V. Willson,Stuart Schwartz,Sanford D. Markowitz	106
12	Increased transversions in a novel mutator colon cancer cell line 1998 ·Oncogene ·James R. Eshleman,Preston S. Donover,Susan J. Littman,Sandra E. Swinler,Guo‐Min Li,James Lutterbaugh,James K. V. Willson,Paul Modrich,W. David Sedwick,Sanford D. Markowitz,Martina Veigl	13
13	Effect of lsopropyl‐β‐D‐thiogalactopyranosid induction of the lac operon on the specificity of spontaneous and doxorubicin‐induced mutations in Escherichia coli 1995 ·Environmental and Molecular Mutagenesis ·Martina Veigl,(unknown),R. David Anderson,Lee M. Akst,Caitlin Sedwick,W. David Sedwick	2
14	Correlation of doxorubicin footprints with deletion endpoints in lacO of E. coli 1995 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·W. David Sedwick,R. David Anderson,(unknown),(unknown),(unknown),Martina Veigl	2
15	Sequencing of double-stranded polymerase chain reaction products for mutation analysis 1993 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·R. David Anderson,(unknown),Dana T. Minnick,(unknown),Martina Veigl,W. David Sedwick	8
16	Excision repair reduces doxorubicin-induced genotoxicity 1993 ·Mutation Research/DNA Repair ·R. David Anderson,Martina Veigl,(unknown),W. David Sedwick	7
17	Specificities mediated by neighboring nucleotides appear to underlie mutation induced by antifolates in E. coli 1991 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Martina Veigl,(unknown),(unknown),W. David Sedwick	13
18	Rapid mapping of deletion and duplication mutations by the polymerase chain reaction 1990 ·Biochemical and Biophysical Research Communications ·R. David Anderson,Martina Veigl,W. David Sedwick	3
19	The uses and limitations of calmodulin antagonists 1989 ·Pharmacology & Therapeutics ·Martina Veigl,Rachel E. Klevit,W. David Sedwick	42
20	DNA base modification: Ionized base pairs and mutagenesis 1987 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·Lawrence C. Sowers,Barbara Ramsay Shaw,Martina Veigl,W. David Sedwick	90

About Martina Veigl

Martina Veigl is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (14 papers), DNA Repair Mechanisms (10 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (853 citations), Cancer Research (619 citations) and Oncology (677 citations). Martina Veigl has collaborated with scholars based in United States, China and Spain. Frequent co-authors include W. David Sedwick, Sanford D. Markowitz, James Lutterbaugh, Paul Modrich, Guo‐Min Li, Thomas Vanaman, Lakshmi Kasturi, James T. Drummond, Sumudra Periyasamy and James K. V. Willson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact